Mid-life changes: you never know what menopause may bring.
[[{"type":"media","view_mode":"media_crop","fid":"29115","attributes":{"alt":"","class":"media-image","id":"media_crop_8715192803647","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3010","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]
Elinzanetant's efficacy for vasomotor symptoms confirmed in phase 3 trial
March 19th 2024Bayer's OASIS 3 trial affirmsed the safety and efficacy of elinzanetant in reducing moderate to severe vasomotor symptoms, bolstering confidence in its potential as a non-hormonal solution for menopause-related issues.
Read More